Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T17:27:58.852Z.
Calculation as of: 2026-10-06T17:27:58.852Z.
Quote observation: 2026-10-06T16:59:37.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 93909054c420831b7a71ade485d1565ba09f3c5b60377b98c71c30749e6fc511
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-01-28.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$108688.00
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30664.00
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6197.00
EV/Sales Ratio
N/A
TTM Avg
7806.53x
3Y Avg
7806.53x
5Y Avg
7806.53x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PRF Technologies Ltd. (PRFX) | $72318.00 | N/A | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $61819.00 | N/A | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $96046.00 | N/A | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108688.00 | N/A | N/A | N/A | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30664.00 | N/A | N/A | N/A | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6197.00 | N/A | 7806.53x | 7806.53x | 7806.53x |
| SciSparc Ltd. (SPRC)vs › | $243502.00 | N/A | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | N/A | N/A | N/A | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | 0.95x | 22.73x | 233.34x | 409.95x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-01-28 | 12.02x |
| 2026-01-27 | 9.97x |
| 2026-01-26 | 26.37x |
| 2026-01-23 | 36.62x |
| 2026-01-22 | 108.37x |
| 2026-01-21 | 119.64x |
| 2026-01-20 | 136.04x |
| 2026-01-16 | 213.94x |
| 2026-01-15 | 54.04x |
| 2026-01-14 | 59.17x |
| 2026-01-13 | 49.94x |
| 2026-01-12 | 45.84x |
| 2026-01-09 | 70.44x |
| 2026-01-08 | 70.44x |
| 2026-01-07 | 6.89x |
| 2025-12-29 | 6.89x |
| 2025-12-26 | 59.17x |
| 2025-12-24 | 76.59x |
| 2025-12-23 | 86.84x |
| 2025-12-22 | 95.04x |
| 2025-12-19 | 87.87x |
| 2025-12-18 | 90.94x |
| 2025-12-17 | 122.72x |
| 2025-12-16 | 137.07x |
| 2025-12-15 | 89.92x |
| 2025-12-12 | 131.94x |
| 2025-12-11 | 162.69x |
| 2025-12-10 | 129.89x |
| 2025-12-09 | 112.47x |
| 2025-12-08 | 122.72x |
| 2025-12-05 | 126.82x |
| 2025-12-04 | 157.57x |
| 2025-12-03 | 116.57x |
| 2025-12-02 | 126.82x |
| 2025-12-01 | 115.54x |
| 2025-11-28 | 128.87x |
| 2025-11-26 | 109.39x |
| 2025-11-25 | 90.94x |
| 2025-11-24 | 85.82x |
| 2025-11-21 | 77.62x |
| 2025-11-20 | 76.59x |
| 2025-11-19 | 87.87x |
| 2025-11-18 | 63.27x |
| 2025-11-17 | 87.87x |
| 2025-11-14 | 94.02x |
| 2025-11-13 | 111.44x |
| 2025-11-12 | 130.92x |
| 2025-11-11 | 88.89x |
| 2025-11-10 | 113.49x |
| 2025-11-07 | 147.32x |
| 2025-11-06 | 188.32x |
| 2025-11-05 | 208.82x |
| 2025-11-04 | 172.94x |
| 2025-11-03 | 229.32x |
| 2025-10-31 | 270.31x |
| 2025-10-30 | 249.82x |
| 2025-10-29 | 280.56x |
| 2025-10-28 | 306.19x |
| 2025-10-27 | 311.31x |
| 2025-10-24 | 304.14x |
| 2025-10-23 | 280.56x |
| 2025-10-22 | 254.94x |
| 2025-10-21 | 290.81x |
| 2025-10-20 | 295.94x |
| 2025-10-17 | 270.31x |
| 2025-10-16 | 272.36x |
| 2025-10-15 | 326.69x |
| 2025-10-14 | 285.69x |
| 2025-10-13 | 254.94x |
| 2025-10-10 | 304.14x |
| 2025-10-09 | 367.69x |
| 2025-10-08 | 393.31x |
| 2025-10-07 | 331.81x |
| 2025-10-06 | 347.19x |
| 2025-10-03 | 342.06x |
| 2025-10-02 | 331.81x |
